![Bernd Kullmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bernd Kullmann
Chief Operating Officer at
SIGILON THERAPEUTICS, INC.
Profile
Bernd Kullmann is currently the SVP-Head Operations & Project Management at Sigilon Therapeutics, Inc. Prior to this, he worked as the Head-Supply Chain at MediVation, Inc. and later at BeiGene Ltd. as the Head-Supply Chain from 2019 to 2022.
Mr. Kullmann holds an MBA from Carnegie Mellon University and an undergraduate degree from Norwich University.
Bernd Kullmann active positions
| Companies | Position | Start |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Operating Officer | - |
Former positions of Bernd Kullmann
| Companies | Position | End |
|---|---|---|
| BEIGENE LTD | Corporate Officer/Principal | 2022-03-31 |
MediVation, Inc. /MA/
 MediVation, Inc. /MA/ Internet Software/ServicesTechnology Services Provides fully automated Web-based communications systems to educate and communicate with patients securely on-line | Corporate Officer/Principal | - |
Training of Bernd Kullmann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MediVation, Inc. /MA/
MediVation, Inc. /MA/ Internet Software/ServicesTechnology Services Provides fully automated Web-based communications systems to educate and communicate with patients securely on-line | Technology Services |
Norwich University
 Norwich University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
- Stock Market
- Insiders
- Bernd Kullmann
